Co-Administration Of Methotrexate And CP-690,550

NCT01745055 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: CP-690,550 (tofacitinib)
DRUG: Methotrexate (MTX)

Sponsor

Pfizer